Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NIAID to study Emergent's group B streptococcus vaccine candidate

Dec. 29, 2006

Imvamune equally immunogenic in HIV-infected subjects as healthy subjects

Dec. 29, 2006

L- and P- selectin antagonists patented by GlycoMimetics

Dec. 22, 2006

Phase III study opens in U.S. for Grazax

Dec. 15, 2006

ALK-Abello and Menarini sign Grazax agreement

Dec. 1, 2006

Banyu launches Pneumovax NP in Japan

Nov. 30, 2006

New deadlines for VaxGen's development of anthrax vaccine

Nov. 30, 2006

Sankyo patents novel compounds for transplant rejection, autoimmune diseases, etc.

Nov. 29, 2006

Phase I/II study investigates Imprime PGG with G-CSF for stem cell mobilization

Nov. 24, 2006

Crucell completes acquisition of SBL Vaccin

Nov. 24, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...